Clinical Trial Update: Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating intraoperative liposomal bupivacaine injection in primary total knee arthroplasty was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Osteoarthritis, Osteoarthritis, Knee | Phase 2, Phase 3 | Status: WITHDRAWN